D. Mcarthur, D. Chute, and J. Villablanca, Moderate and Severe Traumatic Brain Injury: Epidemiologic, Imaging and Neuropathologic Perspectives, Brain Pathology, vol.3, issue.no. 3, pp.185-94, 2004.
DOI : 10.1111/j.1750-3639.2004.tb00052.x

F. Masson, M. Thicoipe, T. Mokni, P. Aye, P. Erny et al., Epidemiology of traumatic comas: a prospective population-based study, Brain Injury, vol.17, issue.4, pp.279-93, 2003.
DOI : 10.1080/0269905021000030805

J. Payen, B. Fauvage, P. Lavagne, and D. Falcon, Traitement de l'oedème cérébral. Conférence d'actualisation Sfar, 2001.

M. Hasselblatt, H. Ehrenreich, and A. Sirén, The Brain Erythropoietin System and its Potential for Therapeutic Exploitation in Brain Disease, Journal of Neurosurgical Anesthesiology, vol.18, issue.2, 2006.
DOI : 10.1097/00008506-200604000-00007

M. Brines and A. Cerami, Opinion: Emerging biological roles for erythropoietin in the nervous system, Nature Reviews Neuroscience, vol.77, issue.6, pp.484-94, 2005.
DOI : 10.1073/pnas.0403172101

S. Genc, T. Koroglu, and K. Genc, Erythropoietin and the nervous system, Brain Research, vol.1000, issue.1-2, pp.19-31, 2004.
DOI : 10.1016/j.brainres.2003.12.037

P. Ghezzi and M. Brines, Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ, pp.37-44, 2004.
DOI : 10.1038/sj.cdd.4401450

H. Ehrenreich, M. Hasselblatt, and C. Dembowski, Erythropoietin therapy for acute stroke is both safe and beneficial, Mol Med, vol.8, issue.8, pp.495-505, 2002.

L. Cherian, J. Goodman, and C. Robertson, Neuroprotection with Erythropoietin Administration Following Controlled Cortical Impact Injury in Rats, Journal of Pharmacology and Experimental Therapeutics, vol.322, issue.2, pp.789-94, 2007.
DOI : 10.1124/jpet.107.119628

M. Brines, P. Ghezzi, and S. Keenan, Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury, Proceedings of the National Academy of Sciences, vol.97, issue.19, pp.10526-10557, 2000.
DOI : 10.1073/pnas.97.19.10526

G. Grasso, A. Sfacteria, F. Meli, V. Fodale, M. Buemi et al., Neuroprotection by erythropoietin administration after experimental traumatic brain injury, Brain Research, vol.1182, pp.99-105, 2007.
DOI : 10.1016/j.brainres.2007.08.078

R. Ning, Y. Xiong, A. Mahmood, Y. Zhang, Y. Meng et al., Erythropoietin promotes neurovascular remodeling and long-term functional recovery in rats following traumatic brain injury, Brain Research, vol.1384, pp.140-50, 2011.
DOI : 10.1016/j.brainres.2011.01.099

Y. Xiong, D. Lu, C. Qu, A. Goussev, T. Schallert et al., Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice, Journal of Neurosurgery, vol.109, issue.3, pp.510-531, 2008.
DOI : 10.3171/JNS/2008/109/9/0510

C. Hartley, M. Varma, J. Fischer, R. Riccardi, J. Strauss et al., Neuroprotective effects of erythropoietin on acute metabolic and pathological changes in experimentally induced neurotrauma, Journal of Neurosurgery, vol.109, issue.4, pp.708-722, 2008.
DOI : 10.3171/JNS/2008/109/10/0708

G. Chen, J. Shi, C. Hang, W. Xie, J. Liu et al., Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: A potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO), Neuroscience Letters, vol.425, issue.3, pp.177-82, 2007.
DOI : 10.1016/j.neulet.2007.08.022

I. Yatsiv, N. Grigoriadis, and C. Simeonidou, Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury, The FASEB Journal, vol.19, issue.12, pp.1701-1704, 2005.
DOI : 10.1096/fj.05-3907fje

Y. Zhang, Y. Xiong, A. Mahmood, Y. Meng, C. Qu et al., Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit, Brain Research, vol.1294, pp.153-64, 2009.
DOI : 10.1016/j.brainres.2009.07.077

A. Mahmood, D. Lu, C. Qu, A. Goussev, Z. Zhang et al., Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin, Journal of Neurosurgery, vol.107, issue.2, pp.392-399, 2007.
DOI : 10.3171/JNS-07/08/0392

O. Verdonck, H. Lahrech, G. Francony, O. Carle, R. Farion et al., Erythropoietin Protects from Post-Traumatic Edema in the Rat Brain, Journal of Cerebral Blood Flow & Metabolism, vol.19, issue.7, pp.1369-76, 2007.
DOI : 10.1097/00004647-199908000-00006

URL : https://hal.archives-ouvertes.fr/inserm-00381772

C. Noguchi, P. Asavaritikrai, R. Teng, and Y. Jia, Role of erythropoietin in the brain, Critical Reviews in Oncology/Hematology, vol.64, issue.2, pp.159-71, 2007.
DOI : 10.1016/j.critrevonc.2007.03.001

M. Digicaylioglu and S. Lipton, Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades, Nature, vol.412, issue.6847, pp.641-648, 2001.
DOI : 10.1038/35088074

T. Mori, X. Wang, J. Jung, T. Sumii, A. Singhal et al., Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects, J Cereb Blood Flow Metab, vol.22, issue.4, pp.444-52, 2002.

N. Otani, H. Nawashiro, S. Fukui, H. Ooigawa, A. Ohsumi et al., Role of the activated extracellular signal-regulated kinase pathway on histological and behavioral outcome after traumatic brain injury in rats, Journal of Clinical Neuroscience, vol.14, issue.1, pp.42-50, 2007.
DOI : 10.1016/j.jocn.2005.11.044

N. Noshita, A. Lewén, T. Sugawara, and P. Chan, Akt Phosphorylation and Neuronal Survival after Traumatic Brain Injury in Mice, Neurobiology of Disease, vol.9, issue.3, pp.294-304, 2002.
DOI : 10.1006/nbdi.2002.0482

E. Kilic, U. Kilic, J. Soliz, C. Bassetti, M. Gassmann et al., Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways, The FASEB Journal, vol.19, issue.14, pp.2026-2034, 2005.
DOI : 10.1096/fj.05-3941fje

S. Valable, G. Francony, P. Bouzat, M. Fevre, N. Mahious et al., The Impact of Erythropoietin on Short-Term Changes in Phosphorylation of Brain Protein Kinases in a Rat Model of Traumatic Brain Injury, Journal of Cerebral Blood Flow & Metabolism, vol.282, issue.2, pp.361-370, 2010.
DOI : 10.1038/jcbfm.2009.222

URL : https://hal.archives-ouvertes.fr/inserm-00517172

A. Marmarou, M. Foda, W. Van-den-brink, J. Campbell, H. Kita et al., A new model of diffuse brain injury in rats, Journal of Neurosurgery, vol.80, issue.2, pp.291-300, 1994.
DOI : 10.3171/jns.1994.80.2.0291

M. Foda and A. Marmarou, A new model of diffuse brain injury in rats, Journal of Neurosurgery, vol.80, issue.2, pp.301-314, 1994.
DOI : 10.3171/jns.1994.80.2.0301

P. Fatouros and A. Marmarou, Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values, Journal of Neurosurgery, vol.90, issue.1, pp.109-124, 1999.
DOI : 10.3171/jns.1999.90.1.0109

S. Subramaniam and K. Unsicker, Extracellular signal-regulated kinase as an inducer of non-apoptotic neuronal death, Neuroscience, vol.138, issue.4, pp.1055-65, 2006.
DOI : 10.1016/j.neuroscience.2005.12.013

S. Namura, K. Iihara, S. Takami, I. Nagata, H. Kikuchi et al., Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia, Proceedings of the National Academy of Sciences, vol.98, issue.20, pp.11569-74, 2001.
DOI : 10.1073/pnas.181213498

A. Sirén, M. Fratelli, M. Brines, C. Goemans, S. Casagrande et al., Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress, Proceedings of the National Academy of Sciences, vol.98, issue.7, pp.4044-4053, 2001.
DOI : 10.1073/pnas.051606598

S. Lee, T. Nguyen, M. Park, K. Kim, K. Cho et al., EPO receptor-mediated ERK kinase and NF-??B activation in erythropoietin-promoted differentiation of astrocytes, Biochemical and Biophysical Research Communications, vol.320, issue.4, pp.1087-95, 2004.
DOI : 10.1016/j.bbrc.2004.06.060

M. Cardone, N. Roy, H. Stennicke, G. Salvesen, T. Franke et al., Regulation of Cell Death Protease Caspase-9 by Phosphorylation, Science, vol.282, issue.5392, pp.1318-1339, 1998.
DOI : 10.1126/science.282.5392.1318

J. Shen, Y. Wu, J. Xu, J. Zhang, S. Sinclair et al., ERK- and Akt-Dependent Neuroprotection by Erythropoietin (EPO) against Glyoxal-AGEs via Modulation of Bcl-xL, Bax, and BAD, Investigative Opthalmology & Visual Science, vol.51, issue.1, pp.35-46, 2010.
DOI : 10.1167/iovs.09-3544

M. Sättler, D. Merkler, K. Maier, C. Stadelmann, H. Ehrenreich et al., Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis, Cell Death and Differentiation, vol.11, issue.2, pp.181-92, 2004.
DOI : 10.1038/sj.cdd.4401504

N. Byts and A. Sirén, Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med, p.4, 2009.

S. Nurko, Anemia in chronic kidney disease: causes, diagnosis, treatment., Cleveland Clinic Journal of Medicine, vol.73, issue.3, pp.289-97, 2006.
DOI : 10.3949/ccjm.73.3.289

M. Tseng, P. Hutchinson, H. Richards, M. Czosnyka, J. Pickard et al., Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial, Journal of Neurosurgery, vol.111, issue.1, pp.171-80, 2009.
DOI : 10.3171/2009.3.JNS081332

R. Nirula, R. Diaz-arrastia, K. Brasel, J. Weigelt, and K. Waxman, Safety and Efficacy of Erythropoietin in Traumatic Brain Injury Patients: A Pilot Randomized Trial, Critical Care Research and Practice, vol.8, issue.8, p.209848, 2010.
DOI : 10.1016/j.transci.2004.05.001

H. Corwin, A. Gettinger, T. Fabian, A. May, R. Pearl et al., Efficacy and Safety of Epoetin Alfa in Critically Ill Patients, New England Journal of Medicine, vol.357, issue.10, pp.965-76, 2007.
DOI : 10.1056/NEJMoa071533

L. Napolitano, T. Fabian, K. Kelly, J. Bailey, E. Block et al., Improved Survival of Critically Ill Trauma Patients Treated With Recombinant Human Erythropoietin, The Journal of Trauma: Injury, Infection, and Critical Care, vol.65, issue.2, pp.285-97, 2008.
DOI : 10.1097/TA.0b013e31817f2c6e

H. Ehrenreich, K. Weissenborn, H. Prange, D. Schneider, C. Weimar et al., Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke, Stroke, vol.40, issue.12, pp.647-56, 2009.
DOI : 10.1161/STROKEAHA.109.564872

M. Leist, P. Ghezzi, and G. Grasso, Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic, Science, vol.305, issue.5681, pp.239-281, 2004.
DOI : 10.1126/science.1098313

P. Bouzat, G. Francony, S. Thomas, S. Valable, F. Mauconduit et al., Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative*, Critical Care Medicine, vol.39, issue.9, pp.2099-105, 2011.
DOI : 10.1097/CCM.0b013e31821cb7b2

URL : https://hal.archives-ouvertes.fr/inserm-00658345